MPA
Marvin & Palmer Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,467
| Closed | -$3.01M | – | 40 |
|
|
2024
Q3 | $3.01M | Sell |
6,467
-215
| -3% | -$100K | 2.52% | 20 |
|
|
2024
Q2 | $2.79M | Buy |
6,682
+7
| +0.1% | +$2.92K | 2.86% | 22 |
|
|
2024
Q1 | $2.79M | Sell |
6,675
-394
| -6% | -$165K | 2.77% | 23 |
|
|
2023
Q4 | $2.88M | Sell |
7,069
-15,182
| -68% | -$6.18M | 3.21% | 14 |
|
|
2023
Q3 | $7.74M | Sell |
22,251
-4,124
| -16% | -$1.43M | 5.02% | 9 |
|
|
2023
Q2 | $9.28M | Sell |
26,375
-16,252
| -38% | -$5.72M | 4.18% | 15 |
|
|
2023
Q1 | $13.4M | Buy |
42,627
+3,472
| +9% | +$1.09M | 6.77% | 1 |
|
|
2022
Q4 | $11.3M | Hold |
39,155
| – | – | 5.96% | 1 |
|
|
2022
Q3 | $11.3M | Sell |
39,155
-1,901
| -5% | -$550K | 6.96% | 1 |
|
|
2022
Q2 | $11.6M | Sell |
41,056
-1,490
| -4% | -$420K | 5.95% | 1 |
|
|
2022
Q1 | $11.1M | Buy |
+42,546
| New | +$11.1M | 5% | 4 |
|
|
2020
Q4 | – | Sell |
-22,999
| Closed | -$6.26M | – | 38 |
|
|
2020
Q3 | $6.26M | Sell |
22,999
-2,549
| -10% | -$694K | 3.3% | 21 |
|
|
2020
Q2 | $7.42M | Buy |
25,548
+4,544
| +22% | +$1.32M | 4.47% | 9 |
|
|
2020
Q1 | $5M | Buy |
+21,004
| New | +$5M | 4.78% | 6 |
|
|
2013
Q3 | – | Sell |
-13,800
| Closed | -$1.11M | – | 82 |
|
|
2013
Q2 | $1.11M | Buy |
+13,800
| New | +$1.11M | 0.6% | 56 |
|